Chirag

Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Thursday, December 21, 2023

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9-10, 2024.

Key Points: 
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9-10, 2024.
  • Chirag will present on January 10th at 11:15 AM PST, and a live webcast will be accessible on the Company's website at https://investors.amneal.com .
  • A replay of the webcast will be available for 30 days following the event.

Institute for Portfolio Alternatives Elects New Board Members for 2023

Retrieved on: 
Friday, December 16, 2022

WASHINGTON, Dec. 16, 2022 /PRNewswire/ -- The Institute for Portfolio Alternatives (IPA) today announced it has elected 11 new directors. The IPA Board of Directors consists of senior executive leaders from all corners of the portfolio diversifying investments industry, each elected to a three-year term effective January 1, 2023. 

Key Points: 
  • WASHINGTON, Dec. 16, 2022 /PRNewswire/ -- The Institute for Portfolio Alternatives (IPA) today announced it has elected 11 new directors.
  • The IPA Board of Directors consists of senior executive leaders from all corners of the portfolio diversifying investments industry, each elected to a three-year term effective January 1, 2023.
  • In addition to naming 11 new directors, the Board of Directors also elected CNL Financial Group's Chirag Bhavsar,as chair-elect for 2023.
  • "The IPA Board brings together a group of leaders who represent our guiding principles as well as the diversity of our community.

Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty

Retrieved on: 
Tuesday, September 6, 2022

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has appointed Gustavo Pesquin as Executive Vice President, Chief Commercial Officer - Specialty, effective September 6, 2022.

Key Points: 
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has appointed Gustavo Pesquin as Executive Vice President, Chief Commercial Officer - Specialty, effective September 6, 2022.
  • Mr. Pesquin received an M.B.A. with a concentration in Management and Strategy, Finance and Accounting from Kellogg GSM, at Northwestern University and a B.A.
  • Amneal Co-Chief Executive Officers Chirag Patel and Chintu Patel said, We are very pleased to welcome Gustavo as our Chief Commercial Officer for Specialty.
  • Mr. Pesquin said, I am very excited to join the Amneal team at this dynamic time.

Kong Inc. Welcomes Chirag Shah as Chief Financial Officer

Retrieved on: 
Thursday, February 24, 2022

Kong Inc. , the cloud connectivity company, today announced the appointment of Chirag Shah as its first chief financial officer (CFO).

Key Points: 
  • Kong Inc. , the cloud connectivity company, today announced the appointment of Chirag Shah as its first chief financial officer (CFO).
  • View the full release here: https://www.businesswire.com/news/home/20220224005321/en/
    Kong Inc. Chief Financial Officer Chirag Shah (Photo: Business Wire)
    Following a year of record growth, Kong is approaching 500 enterprise customers, including some of the worlds biggest brands in financial services, technology, e-commerce and other industries, such as Expedia, GE, GlaxoSmithKline, Honeywell, Miro, Nasdaq, Papa Johns and Verifone.
  • Kong's core open source software Kong Gateway has been downloaded over 280 million times across thousands of organizations.
  • Through true innovation in API and microservices connectivity, Kong is achieving more and more prominence in todays cloud native world with each passing day, said Chirag Shah.